← Today in NEWSDASH.LIVE
Novo Nordisk trial shows semaglutide helped 40% of children
2 outlets
·
Stocks
lean unrated
How each outlet headlined it
Investing.com Stocks
Novo Nordisk trial shows semaglutide helped 40% of children
STAT News
Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.
